Development of an antisense-mediated exon skipping approach as a therapeutic option for the ML II-causing mutation c.3503_3504delTC

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
ESGLD 2017 - Abstract SA - delTC therapy.pdf		92.97 KB	Adobe PDF	Download

Authors

Lysosomal storage disorders (LSDs) are a group of a rare inherited metabolic disorders.

Mucolipidose Tipo II Terapias de Splicing Doenças Genéticas